Myomo Provides Highlights of Today’s Investor & Analyst Day Event
Senior executives to provide an in-depth review of the Company’s business model and discuss long-range aspirational financial metrics BURLINGTON, Mass. (June 18, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor […]
Myomo Reports First Quarter 2025 Financial and Operating Results
Revenue of $9.8 million Record 700 patients added to the pipeline More than 300 Certified Prosthetists Orthotists have completed initial MyoPro® training Conference call being held today at 4:30pm Eastern time BURLINGTON, Mass. (May 7, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality […]
Myomo to Host Investor & Analyst Day Event on June 18, 2025
BURLINGTON, Mass. (May 1, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the Company will be hosting its first-ever Investor & Analyst Day event on Wednesday, June 18, 2025. The event will take […]
Myomo to Report First Quarter 2025 Financial Results on May 7
BURLINGTON, Mass. (April 30, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2025 on May 7, 2025. Read more.
Myomo Launches the MyoPro® 2x
A Major Step Forward in Donning, Fit, and Function – Enhancing User Independence BURLINGTON, Mass. – April 30, 2025 – Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb paralysis and neuromuscular conditions, today announced the launch of the MyoPro 2x, the latest […]
Myomo Announces Upcoming Changes to its Board of Directors
BURLINGTON, Mass. (April 10, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that directors Amy Knapp and Yitzchak Jacobovitz have informed the board they will not stand for re-election as Class II […]
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference BURLINGTON, Mass (March 31, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer and […]
Myomo’s Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million
Generated first-ever positive quarterly cash flow from operations Received a record 233 MyoPro® authorizations and orders with 657 additions to the pipeline Introduces 2025 revenue guidance of $50 million to $53 million Conference call being held today at 4:30pm Eastern time BURLINGTON, Mass. (March 10, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the […]
Myomo to Report Fourth Quarter 2024 Financial Results on March 10
BURLINGTON, Mass. (March 3, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2024 on March 10, 2025. […]
MYOMO, INC. PRICES $15.0 MILLION PUBLIC OFFERING OF COMMON STOCK
BOSTON, December 5, 2024 – Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has priced an underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $5.00 per […]